Physicians' Academy for Cardiovascular Education

Role of GLP-1RA in practice

5 Things a cardiologist needs to know about GLP-1RA

*NEW* Subtitling in English, German, Italian, Spanish, French, and Chinese

10' education - Dec. 3, 2020 - Prof. Eduard Montanya, MD - Barcelona, Spain

Video navigation menu

  • Moving from a glucocentric approach towards a more personalized and CV risk-focused approach 00:35
  • ADA/EASD recommendations for high risk patients or with established ASCVD, CKD or HF 01:10
  • ESC recommendations for patients with ASCVD, or high / very high CV risk 03:47
  • ACC expert consensus decision pathway for CV risk reduction in patients with T2D 04:50
  • ADA/EASD position statement for people without established ASCVD, HF or CKD 05:18
  • Recommendations if there is a need to minimize hypoglycaemia, or to minimize weight gain/promote weight loss 06:00
  • When to initiate a GLP-1 RA with proven CVD benefit in people with or without high risk or clinical ASCVD, CKD or HF? 08:46

Transcript

Show transcript

Educational information

This educational video is part of a series called '5 Things a cardiologist needs to know about GLP-1 RA' that are aimed to guide cardiologists in management of patients with type 2 diabetes, since the cardiology practice is increasingly confronted with these patients. This series covers five topics that help cardiologists understand why GLP-1 RAs are promising as multifactorial treatment for patients with T2D and/or obesity and CVD, and to improve clinical implementation of guidelines recommending treatment with anti-diabetic drugs with CV benefit.

Faculty

Prof. Eduard Montanya, MD - Bellvitge University Hospital, University of Barcelona, Spain

Disclosures

This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.

Or listen to the podcast

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: